Skip to main content

Table 2 Stage 3 (Phase 2) Expert panel ranking exercise results (n = 6)

From: A novel design process for selection of attributes for inclusion in discrete choice experiments: case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke

Attribute

Mean rank (SD)a

Median

Suggested levels

Systolic BP

1.67 (1.2)

1

‱ 140 mm/Hg

‱ 175 mm/Hg

‱ 180 mm/Hg

‱ 185 mm/Hg

‱ 200 mm/Hg

Pre-stroke dependency status

4 (2.6)

4

‱ mRS 1

‱ mRS 2

‱ mRS 3

‱ mRS 4

Pre-stroke cognitive status

5.33 (2.6)

5.5

‱ No impairment

‱ Mild impairment

‱ Moderate impairment

‱ Severe impairment

Stroke Severity (NIHSS)

6.5 (2.9)

7

‱ NIHSS 2

‱ NIHSS 3

‱ NIHSS 5

‱ NIHSS 23

‱ NIHSS 25/26/27

SBP (after reducing)

6.6 (4.7)

5

‱ 185 mm/Hg

‱ 190 mm/Hg

‱ 200 mm/Hg

INR/Anticoagulation

6.7 (2.7)

5.5

‱ < 1.6

‱ < 1.7

‱ < 1.8

‱ 2

Diastolic BP

6.8 (5.2)

6

‱ 100 mm/Hg

‱ 110 mm/Hg

‱ 115 mm/Hg

‱ 120 mm/Hg

Frailty

6.8 (3.9)

7

‱ Composite measure using comorbidities, description of needs (i.e., walking stick)

‱ “patient you [do not] perceive as frail”

Time since symptom onset

7.8 (6.1)

7

‱ < 1 h

‱ < 3 h

‱ 4 h

‱ 4 h 15/20 mins

Recent major surgery

8.3 (3.6)

7.5

‱ Percutaneous coronary intervention

‱ Hip replacement

‱ Laparotomy

Previous stroke

9.2 (4.3)

10.5

‱ Combine with stroke severity?

‱ 2 weeks ago

‱ 4 weeks ago

‱ 3 months ago

Comorbidities

9.8 (2.6)

10

‱ Disability-related

‱ Chronic disease

‱ Illness presenting bleeding risk

Blood glucose level (mmol/L)

10.8 (3.1)

11

‱ 16/19

‱ 22

‱ 25

‱ 27

Patient/relative preferences

11.4 (2.6)

12

‱ No family present

‱ Family present and eager for patient to be treated

‱ Family present and worried about bleeding risk

Willingness to treat blood glucose

11.6 (3.7)

11

‱ Option to treat before thrombolysis decision

‱ Option to present already treated level

Patient age

12.7 (5.7)

14.5

‱ 62/68/75

‱ 80 / 8585

‱ 95

Social support

15 (3.1)

16

‱ Indicator of dependency?

‱ Use as part of frailty composite measure?

Presence of diabetes

15.4 (2.4)

16

‱ No history of diabetes

‱ Patient has diabetes

  1. a Note: Lower mean rank indicates higher perceived importance